- Home
- NAC vs VCEL Comparison
NAC vs VCEL Comparison
Compare NAC & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAC | VCEL |
|---|---|---|
| Founded | 1998 | 1989 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | NAC | VCEL |
|---|---|---|
| Price | $11.58 | $33.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $58.50 |
| AVG Volume (30 Days) | 509.7K | ★ 527.5K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 4.33% | N/A |
| EPS Growth | N/A | ★ 60.00 |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | ★ $276,259,000.00 |
| Revenue This Year | N/A | $19.10 |
| Revenue Next Year | N/A | $17.95 |
| P/E Ratio | ★ N/A | $98.34 |
| Revenue Growth | N/A | ★ 16.45 |
| 52 Week Low | $10.35 | $29.24 |
| 52 Week High | $12.25 | $48.75 |
Technical Indicators
Market Signals| Indicator | NAC | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 29.50 | 44.56 |
| Support Level | $11.57 | $31.24 |
| Resistance Level | $11.64 | $38.48 |
| Average True Range (ATR) | 0.08 | 1.36 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 2.54 | 52.77 |
Price Performance
Historical ComparisonAbout NAC Nuveen California Quality Municipal Income Fund
Nuveen California Quality Municipal Income Fund is a closed-end fixed income mutual fund that prominently invests in tax-exempt municipal bonds from California. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes. Its portfolio mainly includes investment-grade municipal securities of California. The fund targets various sectors such as healthcare, utilities, transportation, and consumer staples.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.